About the conference

The European BioPharm Scale-Up Congress 2007 aims to assist the pharmaceutical and biotech industry to produce biopharmaceuticals as efficiently and effectively as possible .

Our pre-congress day will focus on scale-up of novel therapies. Topics include rapid scale-up of DNA vaccines, vaccines produced in mammalian expression systems, manufacturing antibody derivatives, RNA therapies and nanobodies. The first main congress day will be dedicated to upstream processing. Key sessions are glycosylation in yeast expression systems, progressions in mammalian expression systems and advancing bioprocessing. The second main congress day focuses on downstream processing and the key areas of purification, separation and filtration.

Pre-congress briefing day 11th September 2007

Addressing a pandemic through rapid scale-up
Manufacturing next generation therapies

Day One: Upstream processing 12th September 2007

Excelling in the basics
Scale-up for fermentation and cell culture
Advancing BioProcessing

Day Two: Downstream processing 13th September 2007

Enabling scale-up in downstream processing
BioProcessing monitoring and control